selamectin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antiparasitics, ivermectin derivatives | 5617 | 220119-17-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A broad-spectrum endectocide;
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cats | Kills adult fleas | Indication |
| Cats | Prevent flea eggs from hatching | Indication |
| Cats | Flea infestations caused by Ctenocephalides felis | Indication |
| Cats | Prevention of heartworm disease caused by Dirofilaria immitis | Indication |
| Cats | Ear mite (Otodectes cynotis) infestations | Indication |
| Cats | Treatment and control of roundworms, Toxocara cati | Indication |
| Cats | Treatment and control of intestinal hookworms, infections with Ancylostoma tubaeforme | Indication |
| Dogs | Kills adult fleas | Indication |
| Dogs | Prevent flea eggs from hatching | Indication |
| Dogs | Flea infestations caused by Ctenocephalides felis | Indication |
| Dogs | Prevention of heartworm disease caused by Dirofilaria immitis | Indication |
| Dogs | Ear mite infestations with Otodectes cynotis | Indication |
| Dogs | Treatment and control of sarcoptic mange, Sarcoptes scabiei | Indication |
| Dogs | Tick infestations caused by Dermacentor variabilis | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Revolution | Zoetis Inc. | 1 |
| revolution PLUS | Zoetis Inc. | 2 |
| Selarid | Norbrook Laboratories, Ltd. | 1 |
| SENERGY | Chanelle Pharmaceuticals Manufacturing Ltd. | 1 |
| Revolt | Aurora Pharmaceutical Inc. | 1 |
| SelaSpot | Bimeda Animal Health Limited | 1 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEMBL1908325 | ChEMBL_ID |
| C414354 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB11459 | DRUGBANK_ID |
| 017786 | NDDF |
| C0961275 | UMLSCUI |
| 7888 | INN_ID |
| D05813 | KEGG_DRUG |
| 9578507 | PUBCHEM_CID |
| 1044269 | RXNORM |
| A2669OWX9N | UNII |
Pharmaceutical products:
None